Doctor profile · Federal record

Dr. Lindita Vinca, APRN

Nurse Practitioner · Cheshire, CT

  • NPI 1396093993
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 14 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1781 Highland Ave, Suite 106
Cheshire, CT 064101254
(203) 694-5857
fax (203) 694-5616
Mailing address
1781 Highland Ave Ste 106
Cheshire, CT 064101254

Credentials & registration

NPPES · NUCC
NPI registered
August 2012 — 14 yrs on file
Profile last updated
September 28, 2015
Year of graduation
2012 — 14 yrs since
Specialty taxonomy
363L00000X — NUCC code
State license (1)
Connecticut #5085

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1396093993. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,807
Distinct HCPCS
10
Medicare allowed
$138,639
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,150 197 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 557 474 $81
17000 Destruction of precancer skin growth, 1 growth 320 267 $50
11102 Biopsy of related skin growth, first growth 244 213 $87
99203 New patient office or other outpatient visit, 30-44 minutes 111 111 $100
17110 Destruction of skin growth, 1-14 growths 107 99 $104
99212 Established patient office or other outpatient visit, 10-19 minutes 85 75 $51
99214 Established patient office or other outpatient visit, 30-39 minutes 76 59 $112
11103 Biopsy of related skin growth, each additional growth 52 37 $45
17004 Destruction of precancer skin growth, 15 or more growths 47 39 $152

In context: peer comparison

Among 3 peers in Cheshire Nurse Practitioner, average services per provider: 148. This provider delivers 19× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$143,168
Transactions
418
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, INC. 114 $93,944.28
Abbvie INC. 64 $18,110.49
Genzyme Corporation 19 $11,756.23
Pfizer INC. 23 $4,696.61
Arcutis Biotherapeutics, INC. 36 $4,552.63
Incyte Corporation 28 $3,548.12
Dermavant Sciences, INC. 46 $1,542.14
Eli Lilly and Company 3 $1,389.36
Leo Pharma INC. 10 $837.76
Regeneron Healthcare Solutions, INC. 16 $746.11
Lilly USA, LLC 24 $499.46
E.R. Squibb & Sons, L.L.C. 13 $281.30
Medimetriks Pharmaceuticals, INC. 1 $250.00
Novartis Pharmaceuticals Corporation 10 $247.01
Amgen INC. 11 $228.76

By nature of payment

Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$90,460
Travel and Lodging
$24,580
Consulting Fee
$18,030
Food and Beverage
$9,893
Education
$205

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,012
Patients
580
Total drug cost
$208,939
Drug Type Claims Patients Total cost
Mometasone Furoate Generic 200 129 $3,887
Ketoconazole Generic 174 105 $4,046
Triamcinolone Acetonide Generic 154 96 $2,005
Clobetasol Propionate Generic 123 57 $8,304
Minoxidil Generic 64 22 $949
Mupirocin Generic 56 38 $484
Dupixent Pen (Dupilumab) Brand 46 0 $182,312
Hydrocortisone Generic 33 27 $209
Doxycycline Hyclate Generic 32 17 $996
Ammonium Lactate Generic 31 16 $701

Frequently asked questions

Auto-generated from federal data
What is Dr. Lindita Vinca's medical specialty?
Dr. Lindita Vinca practices Nurse Practitioner in Cheshire, CT.
Where does Dr. Lindita Vinca practice?
Dr. Lindita Vinca practices at 1781 Highland Ave, Cheshire, CT 064101254. Office phone: 2036945857.
What is Dr. Lindita Vinca's NPI?
Dr. Lindita Vinca's National Provider Identifier (NPI) is 1396093993, issued by NPPES.
Does Dr. Lindita Vinca accept Medicare assignment?
Yes. Dr. Lindita Vinca accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lindita Vinca commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.